AI and Healthcare
Tensor Black
AI and Healthcare—with Mika Newton and Dr. Sanjay Juneja is an engaging interview series featuring world-renowned leaders shaping the intersection of artificial intelligence and medicine. Discover how AI is transforming healthcare today, addressing real-world challenges and improving patient outcomes.This series caters to anyone’s listening style with bite-sized, commute-friendly insights and full-length interviews. Join co-hosts Mika Newton, CEO of xCures, and Dr. Sanjay Juneja, a globally recognized oncologist and VP of Clinical AI at Tempus AI, as they explore cutting-edge innovations with industry pioneers.Originally launched as the TARGET: Cancer Podcast in 2021, the series evolved after 75 episodes into a comprehensive platform for AI and healthcare conversations.
Episodes
Mentioned books
Feb 10, 2025 • 11min
What is the biggest hurdle in drug repurposing today?—with Mika Newton
Drug repurposing offers a way to find new treatments using existing medications, but regulatory hurdles and financial disincentives often prevent progress. Mika Newton and Bob Battista examine the challenges of data sharing in the pharmaceutical industry, the high costs of clinical trials, and why companies hesitate to pursue niche indications. They also explore potential policy solutions that could encourage collaboration and make more life-saving treatments accessible to patients.
Feb 3, 2025 • 45min
How AI Screening Is Shaping the Future of Drug Discovery with Tom Neyarapally and Mika Newton
Tom Neyarapally, Founder and CEO at Archetype Therapeutics, and Mika Newton, a notable figure in healthcare innovation, dive into the revolutionary impact of AI on drug discovery. They discuss how machine learning and real-world data are reshaping treatments and reducing costs. The pair emphasizes the importance of collaboration between AI technology and clinical expertise to speed up therapy development. They also tackle challenges such as data access and the need for personalized medication, showcasing a new era of patient-centered approaches.
Jan 26, 2025 • 15min
What’s the future of AI in transforming drug discovery?—with Mika Newton
Tom Neyarapally, an expert in AI-driven drug discovery, shares insights on the groundbreaking role of AI in drug development. He discusses the importance of collaboration between pharmaceutical giants and startups to enhance personalized therapies. Neyarapally emphasizes overcoming data challenges for better patient experiences and the need for accessible datasets for effective AI applications. The conversation also covers economic hurdles in drug discovery and how innovative technologies could make medications more affordable.
Jan 21, 2025 • 13min
How does AI driven screening speed up cancer treatment R&D?—with Mika Newton
Explore how AI is transforming drug discovery by enabling the rapid screening of billions of molecules and identifying new uses for existing drugs. This approach integrates patient data with advanced tools to predict effective treatments for diseases with unmet medical needs, significantly reducing the time and cost of development.
Jan 20, 2025 • 47min
AI's Role in Modern Healthcare with Dr. Debra Patt and Dr. Sanjay Juneja
Dr. Debra Patt, a prominent breast oncologist and leader at Texas Oncology, shares her insights on the transformative role of AI in modern healthcare. She discusses how AI enhances cancer diagnostics, treatment decisions, and patient education. The conversation delves into AI's impact on drug discovery, improving clinical trial efficiency, and reducing costs. They also highlight the need for collaboration between clinicians and technology while addressing data integration challenges and ethical considerations in AI usage, emphasizing personalized patient care.
Jan 15, 2025 • 12min
Patients, data, and profits—with Dr. Sanjay Juneja
Dr. Sanjay Juneja and Dr. Debra Patt discuss patient data in healthcare, including de-identification, data aggregation for research, and the evolving role of AI. They explore how communication systems and real-world evidence improve care delivery, reduce ER visits, and enhance efficiency for healthcare providers.
Jan 13, 2025 • 15min
Why Is The Drug Discovery Market So Slow?—with Mika Newton
Mika Newton and Tom Neyarapally discuss how advancements in data, AI tools, and computing power are transforming drug discovery, particularly in oncology. They explore patient-centric approaches, in silico screening, and strategies to reduce the time and cost of bringing new treatments to market.
Jan 10, 2025 • 5min
Insights from the Chair of the ASCO AI Taskforce—with Dr. Sanjay Juneja
An overview of ASCO's approach to artificial intelligence in cancer care, focusing on responsible use, transparency, and the importance of keeping physicians at the center of decision-making. The clip discusses guidelines, challenges like biases and model limitations, and how AI can complement personalized care.
Jan 7, 2025 • 11min
How is AI Helping Healthcare Providers Today?—with Dr. Sanjay Juneja
Join Dr. Debra Patt, a breast medical oncologist from Texas Oncology, as she shares insights on the transformative impact of AI in healthcare. Discover how AI tools enhance cancer diagnostics and automate clinical documentation, significantly reducing physician workloads. Learn about AI-powered scribe services that allow for real-time patient notes and improve communication. Additionally, the discussion touches on AI's crucial role in drug discovery and optimizing clinical trials, reshaping patient care for the better.
Jan 5, 2025 • 11min
How Can AI Help Reduce The Financial Burden Of The Healthcare System?—with Dr. Sanjay Juneja
Discover how AI is reshaping the financial landscape of healthcare. Learn about innovative tools like ambient listening and real-time monitoring that enhance patient care. Explore the role of AI in educating patients to manage treatment side effects effectively. Delve into groundbreaking advancements in drug discovery and clinical trials, unlocking the potential for personalized therapies that improve outcomes and reduce toxicity. This enlightening discussion underscores the critical intersection of technology and health economics.
